Arthritis Res Ther. 2011 Jun 20;13(3):114. [Epub ahead of print]
Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed.
Denton CP, Avouac J, Behrens F, Furst DE, Foeldvari I, Humbert M, Huscher D, Kowal-Bielecka O, Matucci-Cerinic M, Nash P, Opitz CF, Pittrow D, Rubin LJ, Seibold JR, Distler O.
Centre for Rheumatology, Royal Free Campus, University College Medical School, London, NW3 2PF, UK.
Medicine (Baltimore). 2011 May;90(3):201-11.
Pulmonary hypertension in patients with neurofibromatosis type I.
Montani D, Coulet F, Girerd B, Eyries M, Bergot E, Mal H, Biondi G, Dromer C, Hugues T, Marquette C, O'Connell C, O'Callaghan DS, Savale L, Jaïs X, Dorfmüller P, Begueret H, Bertoletti L, Sitbon O, Bellanné-Chantelot C, Zalcman G, Simonneau G, Humbert M, Soubrier F.
Chest. 2011 Nov;140(5):1274-83. Epub 2011 May 5.
Long-Term Treatment with Sildenafil Citrate in Pulmonary Arterial Hypertension: SUPER-2.
Rubin LJ, Badesch DB, Fleming TR, Galiè N, Simonneau G, Ghofrani HA, Oakes M, Layton G, Serdarevic-Pehar M, McLaughlin VV, Barst RJ; on behalf of the SUPER-2 study group.
Expert Rev Respir Med. 2011 Apr;5(2):217-29; quiz 230-1.
Pulmonary veno-occlusive disease: advances in clinical management and treatments.
Huertas A, Girerd B, Dorfmuller P, O'Callaghan D, Humbert M, Montani D.
J Thorac Cardiovasc Surg. 2011 Mar;141(3):702-10.
Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry.
Mayer E, Jenkins D, Lindner J, D'Armini A, Kloek J, Meyns B, Ilkjaer LB, Klepetko W, Delcroix M, Lang I, Pepke-Zaba J, Simonneau G, Dartevelle P.
Kerckhoff Heart and Lung Center, Bad Nauheim, Germany.
Clin Rev Allergy Immunol. 2011 Mar 11. [Epub ahead of print]
The Role of Inflammation and Autoimmunity in the Pathophysiology of Pulmonary Arterial Hypertension.
Kherbeck N, Tamby MC, Bussone G, Dib H, Perros F, Humbert M, Mouthon L.
Institut Cochin, INSERM U1016, Paris, France.
Rev Mal Respir. 2011 Feb;28(2):129-37. Epub 2011 Feb 16.
[Pulmonary complications in adult sickle cell disease].[Article in French]
Maître B, Mekontso-Dessap A, Habibi A, Bachir D, Parent F, Godeau B, Galacteros F.
Rev Mal Respir. 2011 Feb;28(2):139-51.
[Surgical treatment of pulmonary arterial hypertension].[Article in French]
Fadel E, Mercier O, Mussot S, Fabre D, Humbert M, Simonneau G, Dartevelle P.
Eur Respir J. 2011 Feb;37(2):475-6.
Liver toxicity of sitaxentan in pulmonary arterial hypertension.
Galiè N, Hoeper MM, Gibbs JS, Simonneau G.
Presse Med. 2011 Jan;40(1 Pt 2):e1-2. Epub 2010 Dec 24.
Quarterly medical review: pulmonary involvement in systemic diseases.
Humbert M.